{"id":"https://openalex.org/W4322769171","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-03","title":"Abstract PD17-03: Cell-free DNA monitoring in a phase II study of adjuvant endocrine therapy with CDK 4/6 inhibitor ribociclib for localized HR+/HER2- breast cancer (LEADER)","display_name":"Abstract PD17-03: Cell-free DNA monitoring in a phase II study of adjuvant endocrine therapy with CDK 4/6 inhibitor ribociclib for localized HR+/HER2- breast cancer (LEADER)","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4322769171","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-03"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs22-pd17-03","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006734008","display_name":"Arielle J. Medford","orcid":"https://orcid.org/0000-0002-0829-183X","observed_orcids":["https://orcid.org/0000-0002-0829-183X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arielle J. Medford","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center/Dana Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center/Dana Farber Cancer Institute","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041000949","display_name":"Lauren Scarpetti","orcid":"https://orcid.org/0000-0002-7642-0461","observed_orcids":["https://orcid.org/0000-0002-7642-0461"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren Scarpetti","raw_affiliation_strings":["2University of Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028403057","display_name":"Andrzej Niemierko","orcid":"https://orcid.org/0000-0002-8895-5500","observed_orcids":["https://orcid.org/0000-0002-8895-5500"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrzej Niemierko","raw_affiliation_strings":["3Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057580348","display_name":"Steven Jay Isakoff","orcid":"https://orcid.org/0000-0002-6677-1014","observed_orcids":["https://orcid.org/0000-0002-6677-1014"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven J. Isakoff","raw_affiliation_strings":["4Cancer Center, Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Cancer Center, Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017550097","display_name":"Beverly Moy","orcid":"https://orcid.org/0000-0003-3472-1140","observed_orcids":["https://orcid.org/0000-0003-3472-1140"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beverly Moy","raw_affiliation_strings":["5Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025351031","display_name":"Seth Andrew Wander","orcid":"https://orcid.org/0000-0002-4127-4708","observed_orcids":["https://orcid.org/0000-0002-4127-4708"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seth A. Wander","raw_affiliation_strings":["6Massachusetts General Hospital, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Massachusetts General Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091501124","display_name":"Elizabeth Deluca","orcid":"https://orcid.org/0000-0001-7329-3404","observed_orcids":["https://orcid.org/0000-0001-7329-3404"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Deluca","raw_affiliation_strings":["7Massachusetts General Hospital Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Massachusetts General Hospital Cancer Center","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Elizabeth Abraham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Abraham","raw_affiliation_strings":["8Massachusetts General Hospital Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Massachusetts General Hospital Cancer Center","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101601453","display_name":"Jennifer Adrienne Shin","orcid":"https://orcid.org/0000-0001-6301-6753","observed_orcids":["https://orcid.org/0000-0001-6301-6753"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Shin","raw_affiliation_strings":["9Cancer Center, Massachusetts General hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Cancer Center, Massachusetts General hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111692212","display_name":"Lowell E. Schnipper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lowell Schnipper","raw_affiliation_strings":["10Beth Israel Deaconess Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Beth Israel Deaconess Medical Center","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114043665","display_name":"Amy E. Comander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801622001","display_name":"Newton Wellesley Hospital","ror":"https://ror.org/03hrxmf69","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801622001"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy E. Comander","raw_affiliation_strings":["11Mass General Cancer Center/Newton-Wellesley Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Mass General Cancer Center/Newton-Wellesley Hospital","institution_ids":["https://openalex.org/I2801622001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019296224","display_name":"Therese Marie Mulvey","orcid":"https://orcid.org/0000-0002-7364-2835","observed_orcids":["https://orcid.org/0000-0002-7364-2835"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Therese Mulvey","raw_affiliation_strings":["12Massachusetts General Hospital North Shore Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Massachusetts General Hospital North Shore Cancer Center","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066978727","display_name":"Erik Anthony Spickard","orcid":"https://orcid.org/0000-0002-5024-3559","observed_orcids":["https://orcid.org/0000-0002-5024-3559"]},"institutions":[{"id":"https://openalex.org/I4210124610","display_name":"Natera (United States)","ror":"https://ror.org/02anzyy56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124610"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik Spickard","raw_affiliation_strings":["13Natera","Natera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Natera","institution_ids":["https://openalex.org/I4210124610"]},{"raw_affiliation_string":"Natera","institution_ids":["https://openalex.org/I4210124610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056045630","display_name":"Ekaterina V. Kalashnikova","orcid":"https://orcid.org/0000-0003-1078-0656","observed_orcids":["https://orcid.org/0000-0003-1078-0656"]},"institutions":[{"id":"https://openalex.org/I4210124610","display_name":"Natera (United States)","ror":"https://ror.org/02anzyy56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124610"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ekaterina Kalashnikova","raw_affiliation_strings":["14Natera, San Carlos, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Natera, San Carlos, California","institution_ids":["https://openalex.org/I4210124610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000755839","display_name":"\u00c1ngel Luis Rodr\u00edguez","orcid":"https://orcid.org/0000-0003-3466-7850","observed_orcids":["https://orcid.org/0000-0003-3466-7850"]},"institutions":[{"id":"https://openalex.org/I4210124610","display_name":"Natera (United States)","ror":"https://ror.org/02anzyy56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124610"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angel Rodriguez","raw_affiliation_strings":["15Natera","Natera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Natera","institution_ids":["https://openalex.org/I4210124610"]},{"raw_affiliation_string":"Natera","institution_ids":["https://openalex.org/I4210124610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052735318","display_name":"Leif William Ellisen","orcid":"https://orcid.org/0000-0003-0444-7910","observed_orcids":["https://orcid.org/0000-0003-0444-7910"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leif Ellisen","raw_affiliation_strings":["16Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["17Massachusetts General Hospital Cancer Center, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Massachusetts General Hospital Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018738915","display_name":"Laura M. Spring","orcid":"https://orcid.org/0000-0001-8904-3514","observed_orcids":["https://orcid.org/0000-0001-8904-3514"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura M. Spring","raw_affiliation_strings":["18Massachusetts General Hospital Cancer Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"18Massachusetts General Hospital Cancer Center, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"5_Supplement","first_page":"PD17","last_page":"03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.8339999914169312},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.8569999933242798},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.875},{"id":"https://openalex.org/keywords/localized-breast-cancer","display_name":"localized breast cancer","score":0.875},{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/molecular-residual-disease","display_name":"molecular residual disease","score":0.7450000047683716},{"id":"https://openalex.org/keywords/molecular-recurrence","display_name":"molecular recurrence","score":0.625},{"id":"https://openalex.org/keywords/tumor-dormancy","display_name":"tumor dormancy","score":0.6949999928474426},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.47699999809265137},{"id":"https://openalex.org/keywords/time-to-recurrence","display_name":"time to recurrence","score":0.6290000081062317},{"id":"https://openalex.org/keywords/intermittent-dosing","display_name":"intermittent dosing","score":0.5759999752044678},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.6660000085830688},{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8112025260925293},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7192047238349915},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6731270551681519},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6269190311431885},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5628538131713867},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.53055739402771},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5249079465866089},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5189566016197205},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.4541279375553131},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.40607166290283203},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.11209255456924438}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs22-pd17-03","doi":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs22-pd17-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220688207","https://openalex.org/W4406134918","https://openalex.org/W7129472029","https://openalex.org/W4220721766","https://openalex.org/W3031157601","https://openalex.org/W7202353910","https://openalex.org/W7162628132","https://openalex.org/W4221106610","https://openalex.org/W3195975902","https://openalex.org/W7129761577"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"While":[2,524],"adjuvant":[3,39,76,91,138,170,288,559,618],"endocrine":[4,289,619],"therapy":[5,290,564,620],"(ET)":[6],"reduces":[7],"recurrence":[8,50,226,342,555],"risk":[9,553],"in":[10,37,65,78,129,366,439,556,612],"hormone":[11],"receptor-positive":[12],"(HR+)":[13],"breast":[14,68,81,107,164,629],"cancer,":[15,69],"many":[16],"patients":[17,130,159,285,297,334,370,388,484,499,505,520,530,550],"still":[18],"experience":[19],"disease":[20,45,341,474,509],"recurrence.":[21,386,494],"Adjuvant":[22,83],"therapeutic":[23],"advances":[24],"are":[25],"needed":[26],"to":[27,119,146,187,225,263,384],"improve":[28],"outcomes.":[29],"Meanwhile,":[30],"monitoring":[31,234,545,611],"for":[32,75,105,154,208,253,301,412,546,554,626],"circulating":[33],"tumor":[34,52,252,404],"DNA":[35,610],"(ctDNA)":[36],"the":[38,96,121,124,230,238,250,273,292,367,394,440,481,528,557,636],"setting":[40],"may":[41,548],"detect":[42],"molecular":[43,49],"residual":[44],"and/or":[46],"emergences":[47],"of":[48,90,99,123,137,141,143,174,181,189,249,261,275,330,346,377,396,423,512,518,617,635],"from":[51,351],"dormancy.":[53],"Cyclin-dependent":[54],"kinase":[55],"4":[56],"and":[57,70,149,166,277,291,318,354,380,442,455,460,503,536,561],"6":[58],"(CDK":[59],"4/6)":[60],"inhibitors":[61],"have":[62,86,488,492,533,537],"shown":[63],"efficacy":[64],"HR+/HER2-":[66,80,106,163,628],"metastatic":[67,473,508],"abemaciclib":[71],"is":[72,526],"now":[73],"approved":[74],"use":[77,89],"high-risk":[79],"cancer.":[82],"clinical":[84,117,385],"trials":[85],"evaluated":[87],"upfront":[88],"CDK":[92,102,125,622],"4/6":[93,103,126,623],"inhibition;":[94],"however,":[95],"optimal":[97],"timing":[98],"adding":[100],"a":[101,113,241,307,327,419,613],"inhibitor":[104,127,218,294,624],"cancer":[108,165,630],"remains":[109],"unknown.":[110],"We":[111],"conducted":[112],"prospective":[114],"phase":[115,614],"II":[116,615],"trial":[118,147],"evaluate":[120],"addition":[122],"ribociclib":[128,191,337,513,625],"with":[131,176,215,259,287,343,374,437,514,621],"at":[132,177,272,348,359,393,452,467,551],"least":[133,178],"one":[134,179,188,209,517],"remaining":[135,529],"year":[136,180,350],"ET":[139,144,171],"regardless":[140],"duration":[142],"prior":[145,383],"enrollment,":[148],"we":[150],"prospectively":[151],"collected":[152,271],"plasma":[153],"ctDNA":[155,233,256,302,309,316,324,362,392,402,433,450,462,535,547],"analysis.":[156],"Methods:":[157],"Eligible":[158],"had":[160,167,298,306,313,321,389,400,447,500],"Stage":[161],"I-III":[162],"been":[168],"on":[169,245,410],"(any":[172],"number":[173],"years)":[175],"treatment":[182],"remaining.":[183],"Patients":[184,211],"were":[185,212,270],"randomized":[186],"two":[190],"schedules:":[192],"continuous":[193],"(400":[194],"mg":[195,202],"daily,":[196],"28-day":[197,206],"cycle)":[198,207],"or":[199],"intermittent":[200],"(600":[201],"daily":[203],"days":[204,453],"1-21,":[205],"year.":[210],"concurrently":[213],"treated":[214,286],"an":[216],"aromatase":[217],"(plus":[219],"GnRH":[220],"agonist,":[221],"if":[222],"premenopausal).":[223],"Time":[224],"was":[227,235,363],"calculated":[228],"using":[229,237],"Kaplan-Meier":[231],"method.":[232],"performed":[236],"SignateraTM":[239],"platform,":[240],"tumor-informed":[242],"assay":[243,257],"based":[244],"whole":[246],"exome":[247],"sequencing":[248],"primary":[251],"multiplex":[254],"PCR-NGS":[255],"design":[258],"targeting":[260],"up":[262],"16":[264],"single":[265,308],"nucleotide":[266],"variants.":[267],"Plasma":[268],"samples":[269,299],"start":[274,395],"ribociclib/ET":[276,411,429,459],"serially":[278],"during":[279],"follow-up":[280,329,525],"visits.":[281],"Results:":[282],"Among":[283,480],"81":[284],"CDK4/6":[293],"ribociclib,":[295],"42":[296],"suitable":[300],"analysis:":[303],"3":[304,322],"(7%)":[305],"test,":[310],"17":[311],"(40%)":[312],"2":[314,333,360,369,448,498],"serial":[315,323],"tests,":[317],"22":[319],"(52%)":[320],"tests.":[325],"After":[326],"median":[328],"20":[331],"months,":[332,414],"who":[335,485],"received":[336],"(intermittent":[338],"dosing)":[339],"experienced":[340,372,493],"recurrence-free":[344],"survival":[345],"100%":[347],"1":[349],"study":[352,543,616],"entry":[353],"97%":[355],"(95%":[356],"CI":[357],"88-99%)":[358],"years.":[361],"detected":[364],"exclusively":[365],"only":[368,497],"that":[371],"recurrence,":[373],"lead":[375],"times":[376],"7":[378,475],"months":[379,382,422,431,476],"8":[381],"Both":[387],"no":[390],"detectable":[391,401,489,501,534],"ribociclib/ET.":[397,479],"One":[398,425],"patient":[399,446],"[mean":[403],"molecules/mL":[405],"(MTM/mL)":[406],"=":[407,465],"0.1]":[408],"while":[409,457],"5":[413],"after":[415,427,432,477,510],"which":[416],"she":[417,435],"completed":[418],"full":[420],"12":[421],"treatment.":[424],"month":[426],"completing":[428,478],"(8":[430],"detection),":[434],"presented":[436],"metastases":[438],"liver":[441],"bones.":[443],"The":[444],"second":[445],"negative":[449],"tests":[451],"0":[454],"147":[456],"receiving":[458],"became":[461],"positive":[463],"(MTM/mL":[464],"0.1)":[466],"day":[468],"350.":[469],"She":[470],"developed":[471,506,521,539],"CNS-only":[472,522],"other":[482],"40":[483],"did":[486,531],"not":[487,532,538],"ctDNA,":[490,502],"none":[491],"Conclusions:":[495],"Overall,":[496],"both":[504],"recurrent":[507,540],"completion":[511],"ET.":[515],"Notably,":[516],"these":[519],"disease.":[523,541],"early,":[527],"This":[542],"suggests":[544],"identify":[549],"increased":[552],"extended":[558],"period":[560],"potentially":[562],"guide":[563],"escalation.":[565],"Citation":[566],"Format:":[567],"Arielle":[568],"J.":[569,576],"Medford,":[570],"Lauren":[571],"Scarpetti,":[572],"Andrzej":[573],"Niemierko,":[574],"Steven":[575],"Isakoff,":[577],"Beverly":[578],"Moy,":[579],"Seth":[580],"A.":[581],"Wander,":[582],"Elizabeth":[583,585],"Deluca,":[584],"Abraham,":[586],"Jennifer":[587],"Shin,":[588],"Lowell":[589],"Schnipper,":[590],"Amy":[591],"E.":[592],"Comander,":[593],"Therese":[594],"Mulvey,":[595],"Erik":[596],"Spickard,":[597],"Ekaterina":[598],"Kalashnikova,":[599],"Angel":[600],"Rodriguez,":[601],"Leif":[602],"Ellisen,":[603],"Aditya":[604],"Bardia,":[605],"Laura":[606],"M.":[607],"Spring.":[608],"Cell-free":[609],"localized":[627],"(LEADER)":[631],"[abstract].":[632],"In:":[633],"Proceedings":[634],"2022":[637,643],"San":[638,646],"Antonio":[639],"Breast":[640],"Cancer":[641,652],"Symposium;":[642],"Dec":[644],"6-10;":[645],"Antonio,":[647],"TX.":[648],"Philadelphia":[649],"(PA):":[650],"AACR;":[651],"Res":[653],"2023;83(5":[654],"Suppl):Abstract":[655],"nr":[656],"PD17-03.":[657]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-03-03T00:00:00"}